mdl 29311 has been researched along with cystine in 1 studies
| Studies (mdl 29311) | Trials (mdl 29311) | Recent Studies (post-2010) (mdl 29311) | Studies (cystine) | Trials (cystine) | Recent Studies (post-2010) (cystine) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 6,431 | 97 | 1,084 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doggrell, SA | 1 |
1 other study(ies) available for mdl 29311 and cystine
| Article | Year |
|---|---|
Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?
Topics: Adjuvants, Immunologic; Animals; Arteriosclerosis; Benzhydryl Compounds; Cystine; Dermatitis, Contact; Mice; Mice, Inbred BALB C; Phenols; Probucol; Rabbits | 2002 |